Effect of Cosolutes on the Aggregation of a Tau Fragment: A Combined Experimental and Simulation Approach

J Phys Chem B. 2023 May 11;127(18):4022-4031. doi: 10.1021/acs.jpcb.3c00433. Epub 2023 May 2.

Abstract

The intrinsically disordered protein Tau represents the main component of neurofibrillary tangles that are a hallmark of Alzheimer's disease. A small fragment of Tau, known as paired helical filament 6 (PHF6), is considered to be important for the formation of the β-structure core of the fibrils. Here we study the aggregation of this fragment in the presence of different cosolutes, including urea, TMAO, sucrose and 2-hydroxypropyl-β-cyclodextrin (2-HPβCD), using both experiments and molecular dynamics simulations. A novel implicit solvation approach (MIST - Model with Implicit Solvation Thermodynamics) is used, where an energetic contribution based on the concept of transfer free energies describes the effect of the cosolutes. The simulation predictions are compared to thioflavin-T and atomic force microscopy results, and the good agreement observed confirms the predictive ability of the computational approach herein proposed. Both simulations and experiments indicate that PHF6 aggregation is inhibited in the presence of urea and 2-HPβCD, while TMAO and sucrose stabilize associated conformations. The remarkable ability of HPβCD to inhibit aggregation represents an extremely promising result for future applications, especially considering the widespread use of this molecule as a drug carrier to the brain and as a solubilizer/excipient in pharmaceutical formulations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / metabolism
  • Humans
  • Molecular Dynamics Simulation
  • Urea
  • tau Proteins* / chemistry

Substances

  • trimethyloxamine
  • tau Proteins
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Urea